Immunotherapy with either antithymocyte globulin (ATG) or antilymphocyte globulin (ALG) is the primary treatment for those children not candidates for bone marrow transplant.
采用抗胸腺细胞球蛋白(atg)或抗淋巴细胞球蛋白(ALG)免疫疗法是不适宜于骨髓移植患儿的主要治疗方法。
AIM To explore the effect of low-dose and short-term antithymocyte globulin(ATG) in treatment of early steroid-resistant rejection after renal transplantation.
目的探讨低剂量、短疗程的抗胸腺细胞球蛋白（ATG）治疗肾移植后早期激素耐受性排斥反应的疗效。
Objective To analyze effects of antithymocyte globulin(ATG) in preventing the occurrence of graft-versus-host disease(GVHD) in allogeneic stem cells transplantation.
目的分析异体造血干细胞移植前加用抗T淋巴细胞球蛋白（ATG）预防移植物抗宿主反应（GVHD）的疗效。
Objective To analyze effects of antithymocyte globulin(ATG) in preventing the occurrence of graft-versus-host disease(GVHD) in allogeneic stem cells transplantation.
目的分析异体造血干细胞移植前加用抗T淋巴细胞球蛋白（ATG）预防移植物抗宿主反应（GVHD）的疗效。
应用推荐